| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/29/2004 | US20040147552 Leukotriene antagonist; trauma spinal cord injuries; herpes virus viricides; antiinflammatory agents; central nervous system disorders |
| 07/29/2004 | US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 07/29/2004 | US20040147550 Contraceptives; hormone sensitive disease; aging resistance; antidepressants; sexual disorders ; osteoporosis; hormone replacement therapy |
| 07/29/2004 | US20040147549 Antiviral compounds |
| 07/29/2004 | US20040147547 HIV-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 07/29/2004 | US20040147546 Heterocyclic compounds |
| 07/29/2004 | US20040147545 Therapy for infection |
| 07/29/2004 | US20040147544 Pde4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |
| 07/29/2004 | US20040147542 Chemical compounds |
| 07/29/2004 | US20040147541 Using rapamycin; antitumor agents; angiogenesis inhibitors |
| 07/29/2004 | US20040147540 Compositions and methods for inhibiting platelet activation and thrombosis |
| 07/29/2004 | US20040147539 Spermicidal and/or antifungal composition and methods of using the same |
| 07/29/2004 | US20040147538 Fused heterocyclic compounds |
| 07/29/2004 | US20040147537 Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
| 07/29/2004 | US20040147536 Remedies for sepsis |
| 07/29/2004 | US20040147534 Topical composition and method for treating occlusive wounds |
| 07/29/2004 | US20040147531 Neurodegradation diseases; alzheimer's disease; down's syndrome; antidiabetic agents |
| 07/29/2004 | US20040147529 Preferentially substituted calcium channel blockers |
| 07/29/2004 | US20040147528 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; |
| 07/29/2004 | US20040147527 Pneumonia therapy; antibiotic resistance bacteria |
| 07/29/2004 | US20040147526 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147521 Compositions comprising zopiclone derivatives and methods of making and using the same |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147516 Blocking interleukins; antiinflammatory agents; autoimmune diseases ; antiarthritic agents; osteoporosis |
| 07/29/2004 | US20040147513 New medicaments for the treatment of chronic obstructive pulmonary disease |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147511 Prevent premature labor; dymenorrhea |
| 07/29/2004 | US20040147510 Administering serotonine receptor antagonist and adrenaline reuptake inhibitor |
| 07/29/2004 | US20040147509 Method of treating functional bowel disorders |
| 07/29/2004 | US20040147508 Biologically active methylene blue derivatives |
| 07/29/2004 | US20040147507 Compositions useful as inhibitors of JAK and other protein kinases |
| 07/29/2004 | US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse |
| 07/29/2004 | US20040147504 Therapy for neuropathic pain; antiinflammatory agents |
| 07/29/2004 | US20040147501 Photodynamic therapy |
| 07/29/2004 | US20040147500 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 07/29/2004 | US20040147499 Chlorins and purpurins |
| 07/29/2004 | US20040147498 Combinations of superoxide dismutase mimetics and nonsteroidal analgesic / anti-inflammatory drugs |
| 07/29/2004 | US20040147495 Sapogenin derivatives, their synthesis and use, and methods based upon their use |
| 07/29/2004 | US20040147494 Use |
| 07/29/2004 | US20040147493 Synergistic compositions for the selective control of tumor tissue |
| 07/29/2004 | US20040147492 Methods of treating acne |
| 07/29/2004 | US20040147491 Prevent, maintenance of Dna damage; administering compound which forms nicotinamide-adenine dinucleotide |
| 07/29/2004 | US20040147490 Immunosuppressants |
| 07/29/2004 | US20040147489 Haloacetamide and azide substituted compounds and methods of use thereof |
| 07/29/2004 | US20040147488 Method of modifying the release profile of sustained release compositions |
| 07/29/2004 | US20040147487 Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
| 07/29/2004 | US20040147486 Antitumor, anticancer agents; osteoporosis; bone disorders; Paget's disorders |
| 07/29/2004 | US20040147484 Compositions for delivering bisphosphonates |
| 07/29/2004 | US20040147482 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 07/29/2004 | US20040147481 For the manufacture of a medicament for therapy of gastric acid-related diseases and gastro intestinal inflammatory diseases in animals and man, such as gastric ulcer, duodenal ulcer, reflex oesophagitis and gastritis |
| 07/29/2004 | US20040147480 Prophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds |
| 07/29/2004 | US20040147478 Administering to the patient a combination of a therapeutically effective amount of a MEK inhibitor and a therapeutically effective amount of capecitabine |
| 07/29/2004 | US20040147476 For therapy and prophylaxis of virus infections, other pathogenic infections or cancers |
| 07/29/2004 | US20040147473 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 07/29/2004 | US20040147472 Antisense modulation of transforming growth factor beta receptor II expression |
| 07/29/2004 | US20040147469 Inhibiting the expression of primary proteoglycans; inhibiting the expression and/or activity of a chain initiation enzyme; inhibiting the expression and/or activity of a chain elongation enzyme |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147464 For therapy |
| 07/29/2004 | US20040147463 For therapy of cancer |
| 07/29/2004 | US20040147462 Method for treating roundworm infestations in animals |
| 07/29/2004 | US20040147460 For reducing total weight, and reducing body fat mass |
| 07/29/2004 | US20040147459 Administering a dosage of one to two teaspoons of D-mannose to the patient three times a day with meals for one to two weeks or until the symptoms subside |
| 07/29/2004 | US20040147458 Compositions to reduce exercise-induced swelling of joints |
| 07/29/2004 | US20040147457 Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 07/29/2004 | US20040147456 For therapy and prophylaxis of thrombolytic condition |
| 07/29/2004 | US20040147455 Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof |
| 07/29/2004 | US20040147453 Multivalent metal salts of boronic acids |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147445 For therapy and prophylaxis of arthritis and other inflammatory and autoimmune diseases |
| 07/29/2004 | US20040147441 Methods and reagents for preventing bacteremias |
| 07/29/2004 | US20040147438 For therapy of neuroblastoma |
| 07/29/2004 | US20040147434 Use of enzyme inhibitors of the dipeptidypeptidase iv (ec3.3.14.5) in addition to the aminopeptidase n (ec 3.4.11.2), individually or in a combination thereof, and pharmaceutical preparations thereof for the prevention and/or therapy of ischaemia-caused acute and chronic neurodegenerative process and illnesses, for example |
| 07/29/2004 | US20040147430 Using compounds stimulating secretion of insulin, glucosidase inhibitors, thiazolidinediones, insulin, agents enhancing sensitivity to insulin, glucagon-like peptide-1 (GLP-1), PPAR alpha / gamma agonists, meglitinide and aP2 inhibitors |
| 07/29/2004 | US20040147428 Methods of treatment using an inhibitor of epidermal growth factor receptor |
| 07/29/2004 | US20040147010 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 07/29/2004 | US20040146994 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation |
| 07/29/2004 | US20040146993 Isolating chondroitin sulfate |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146955 CA IX-specific inhibitors |
| 07/29/2004 | US20040146953 Assay |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146856 Viral vector coding antiproliferative agent for treatment of tumors; antitumor agents and artificial chromosome gene therapy |
| 07/29/2004 | US20040146635 Production of polygalacturonides and their use in food additives |
| 07/29/2004 | US20040146595 Breast cancer ; therapy containing plant extracts |
| 07/29/2004 | US20040146593 Herbal drug composition for cartilage protection |
| 07/29/2004 | US20040146591 Solvent extraction, mixing with aqueous solution; drying; sterilization; drugs, food; aging resistance, cognition activators , brain disorders; incontinence; Alzheimer's disease, autism, Parkinson's disease, antiarthritic agents |
| 07/29/2004 | US20040146590 Administering vanilla receptor antagonist; killing ganglions; analgesics, antiinflammatory agent |
| 07/29/2004 | US20040146586 Pretreatment therapy; reducing stent thrombosis |
| 07/29/2004 | US20040146585 Side effect reduction of cancer therapy; using sodium thiosulfate |
| 07/29/2004 | US20040146583 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146582 Kits; administering dosage cycles; leukemia therapy |
| 07/29/2004 | US20040146581 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146580 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146579 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146578 Kits; administering cycle; leukemia therapy |
| 07/29/2004 | US20040146577 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146576 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 07/29/2004 | US20040146575 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |